Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.8557
-0.0713 (-7.69%)
At close: Nov 17, 2026, 4:00 PM EST
0.8557
0.00 (0.00%)
After-hours: Nov 17, 2026, 4:00 PM EST

MTNB Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1.9447.284.796.8321.03
Short-Term Investments
---8.9721.9328.59
Cash & Short-Term Investments
1.9447.2813.7628.7649.62
Cash Growth
-64.38%-45.10%-47.05%-52.18%-42.04%-15.43%
Prepaid Expenses
0.130.030.691.745.721.32
Other Current Assets
0.050.050.050.050.050.05
Total Current Assets
2.124.088.0315.5434.5350.99
Property, Plant & Equipment
-0.672.165.015.735.78
Goodwill
---1.341.341.34
Long-Term Deferred Charges
2.262.262.263.023.023.02
Other Long-Term Assets
-0.20.20.20.20.2
Total Assets
4.387.2112.6425.144.8261.33

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.780.320.10.510.620.94
Accrued Expenses
0.420.451.811.452.291.92
Current Portion of Leases
00.70.770.660.570.56
Current Unearned Revenue
----0.720.03
Other Current Liabilities
----0.090.9
Total Current Liabilities
1.191.462.672.624.294.35
Long-Term Leases
00.662.132.93.564.14
Long-Term Deferred Tax Liabilities
0.260.260.260.340.340.34
Total Liabilities
1.452.385.055.868.188.83

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
-00-0.020.02
Additional Paid-In Capital
225.85215.62207.41195.04190.07184.25
Retained Earnings
-222.92-210.79-199.82-175.57-152.63-131.63
Comprehensive Income & Other
----0.22-0.82-0.15
Total Common Equity
2.934.837.5919.2536.6452.49
Shareholders' Equity
2.934.837.5919.2536.6452.49
Total Liabilities & Equity
4.387.2112.6425.144.8261.33

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
01.352.893.564.124.7
Net Cash (Debt)
1.932.654.3910.224.6444.92
Net Cash Growth
-37.70%-39.75%-56.96%-58.60%-45.15%-18.22%
Net Cash Per Share
3.477.2513.5335.2185.23160.29
Filing Date Shares Outstanding
1.110.430.340.290.290.29
Total Common Shares Outstanding
1.10.430.340.290.290.29
Working Capital
0.932.615.3612.9230.2546.65
Book Value Per Share
2.6611.3122.3866.44126.47182.04
Tangible Book Value
2.934.837.5917.9135.351.16
Tangible Book Value Per Share
2.6611.3122.3861.83121.86177.41
Machinery
--1.542.462.311.64
Leasehold Improvements
-0.170.991.161.160.94
SEC Filings: 10-K · 10-Q